Strata Skin Sciences Cash on Hand 2010-2025 | SSKN
Strata Skin Sciences cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Strata Skin Sciences Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $9 |
| 2023 | $8 |
| 2022 | $7 |
| 2021 | $13 |
| 2020 | $18 |
| 2019 | $16 |
| 2018 | $16 |
| 2017 | $4 |
| 2016 | $4 |
| 2015 | $3 |
| 2014 | $11 |
| 2013 | $4 |
| 2012 | $8 |
| 2011 | $28 |
| 2010 | $31 |
| 2009 | $30 |
| Strata Skin Sciences Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $8 |
| 2024-12-31 | $9 |
| 2024-09-30 | $8 |
| 2024-06-30 | $7 |
| 2024-03-31 | $7 |
| 2023-12-31 | $8 |
| 2023-09-30 | $8 |
| 2023-06-30 | $10 |
| 2023-03-31 | $4 |
| 2022-12-31 | $7 |
| 2022-09-30 | $9 |
| 2022-06-30 | $10 |
| 2022-03-31 | $11 |
| 2021-12-31 | $13 |
| 2021-09-30 | $13 |
| 2021-06-30 | $17 |
| 2021-03-31 | $18 |
| 2020-12-31 | $18 |
| 2020-09-30 | $18 |
| 2020-06-30 | $19 |
| 2020-03-31 | $16 |
| 2019-12-31 | $16 |
| 2019-09-30 | $16 |
| 2019-06-30 | $16 |
| 2019-03-31 | $16 |
| 2018-12-31 | $16 |
| 2018-09-30 | $16 |
| 2018-06-30 | $14 |
| 2018-03-31 | $3 |
| 2017-12-31 | $4 |
| 2017-09-30 | $3 |
| 2017-06-30 | $4 |
| 2017-03-31 | $4 |
| 2016-12-31 | $4 |
| 2016-09-30 | $3 |
| 2016-06-30 | $3 |
| 2016-03-31 | $3 |
| 2015-12-31 | $3 |
| 2015-09-30 | $3 |
| 2015-06-30 | $6 |
| 2015-03-31 | $8 |
| 2014-12-31 | $11 |
| 2014-09-30 | $14 |
| 2014-06-30 | $4 |
| 2014-03-31 | $8 |
| 2013-12-31 | $4 |
| 2013-09-30 | $3 |
| 2013-06-30 | $15 |
| 2013-03-31 | $22 |
| 2012-12-31 | $8 |
| 2012-09-30 | $13 |
| 2012-06-30 | $17 |
| 2012-03-31 | $22 |
| 2011-12-31 | $28 |
| 2011-09-30 | $17 |
| 2011-06-30 | $21 |
| 2011-03-31 | $26 |
| 2010-12-31 | $31 |
| 2010-09-30 | $36 |
| 2010-06-30 | $25 |
| 2010-03-31 | $30 |
| 2009-12-31 | $30 |
| 2009-09-30 | $25 |
| 2009-06-30 | $8 |
| 2009-03-31 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.431B | 52.92 |
| Hims & Hers Health (HIMS) | United States | $10.838B | 112.61 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.445B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.743B | 58.48 |
| Hinge Health (HNGE) | United States | $3.360B | 0.00 |
| Privia Health (PRVA) | United States | $2.603B | 177.92 |
| Enovis (ENOV) | United States | $1.886B | 10.52 |
| Phreesia (PHR) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.514B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| 10x Genomics (TXG) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.439B | 66.87 |
| Evolent Health (EVH) | United States | $1.367B | 116.40 |
| Omnicell (OMCL) | United States | $1.355B | 23.90 |
| Claritev (CTEV) | United States | $0.794B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.443B | 132.50 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 754.67 |
| Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.268B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.217B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.075B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |